Veterinary Biologics Market by Product (Vaccines, Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), Animal Type (Companion Animals, Canine, Avian, Feline, Livestock), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The Veterinary Biologics market size is projected to reach a CAGR of 6.6% from 2022 to 2028.
Veterinary Biologics are basically antigen, antitoxin and vaccine manufactured from the living organisms. Biologics are such that they leave no residue in the body of the animal. Animal and Plant Health Inspection Service (APHIS) is the regulatory body that licence and ensures the safety, purity and effectiveness of the biologics.
Increase R&D in the sector along with the pet owner being more aware and concerned about the pet health are some of the factors that have supported long-term expansion for Veterinary Biologics Market.
COVID-19 had a positive effect on the market, as the pet owners were more aware and concerned about their pets ever then before.
North America is the most rapidly growing market and offers a huge opportunity for the industry, whose growth is driven by the favourable governmental policies along with people getting more concerned about their pets.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Growth Rate |
CAGR of 6.6% during the forecasting period, 2022-2028 |
Historical Data |
2019-2020 |
Forecast Years |
2022-2028 |
Base Year |
2021 |
Units Considered |
Revenue in USD billion and CAGR from 2022 to 2028 |
Report Segmentation |
Product, animal type, disease type, distribution channel and region. |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Zoetis, Inc., Merck Animal Health, Boehringer Ingelheim GmbH, Bayer AG, Eli Lilly & Company, Abaxis, OMEGA, Hebei Veyong Animal Pharmaceutical Co., Ltd., Other prominent players |
Available Customization |
In addition to the market data for Veterinary Biologics Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Veterinary Biologics Market is segmented into product, animal type, disease type, distribution channel and region.